View in EDS

Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis.

Saved in:
Bibliographic Details
Title: Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis.
Authors: Radue EW; Medical Image Analysis Center, University Hospital Basel, Schanzenstrasse 55, 1st Floor, CH 4031, Basel, Switzerland. eradue@uhbs.ch, Stuart WH, Calabresi PA, Confavreux C, Galetta SL, Rudick RA, Lublin FD, Weinstock-Guttman B, Wynn DR, Fisher E, Papadopoulou A, Lynn F, Panzara MA, Sandrock AW
Corporate Authors: SENTINEL Investigators
Source: Journal of the neurological sciences [J Neurol Sci] 2010 May 15; Vol. 292 (1-2), pp. 28-35. Date of Electronic Publication: 2010 Mar 16.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0375403 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-5883 (Electronic) Linking ISSN: 0022510X NLM ISO Abbreviation: J Neurol Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 20236661
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Radue+EW%22">Radue EW</searchLink>; Medical Image Analysis Center, University Hospital Basel, Schanzenstrasse 55, 1st Floor, CH 4031, Basel, Switzerland. eradue@uhbs.ch<br /><searchLink fieldCode="AU" term="%22Stuart+WH%22">Stuart WH</searchLink><br /><searchLink fieldCode="AU" term="%22Calabresi+PA%22">Calabresi PA</searchLink><br /><searchLink fieldCode="AU" term="%22Confavreux+C%22">Confavreux C</searchLink><br /><searchLink fieldCode="AU" term="%22Galetta+SL%22">Galetta SL</searchLink><br /><searchLink fieldCode="AU" term="%22Rudick+RA%22">Rudick RA</searchLink><br /><searchLink fieldCode="AU" term="%22Lublin+FD%22">Lublin FD</searchLink><br /><searchLink fieldCode="AU" term="%22Weinstock-Guttman+B%22">Weinstock-Guttman B</searchLink><br /><searchLink fieldCode="AU" term="%22Wynn+DR%22">Wynn DR</searchLink><br /><searchLink fieldCode="AU" term="%22Fisher+E%22">Fisher E</searchLink><br /><searchLink fieldCode="AU" term="%22Papadopoulou+A%22">Papadopoulou A</searchLink><br /><searchLink fieldCode="AU" term="%22Lynn+F%22">Lynn F</searchLink><br /><searchLink fieldCode="AU" term="%22Panzara+MA%22">Panzara MA</searchLink><br /><searchLink fieldCode="AU" term="%22Sandrock+AW%22">Sandrock AW</searchLink>
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22SENTINEL+Investigators%22">SENTINEL Investigators</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220375403%22">Journal of the neurological sciences</searchLink> [J Neurol Sci] 2010 May 15; Vol. 292 (1-2), pp. 28-35. <i>Date of Electronic Publication: </i>2010 Mar 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>0375403 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1878-5883 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220022510X%22">0022510X </searchLink><i>NLM ISO Abbreviation: </i>J Neurol Sci <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=20236661
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jns.2010.02.012
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 28
    Titles:
      – TitleFull: Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Radue EW
      – PersonEntity:
          Name:
            NameFull: Stuart WH
      – PersonEntity:
          Name:
            NameFull: Calabresi PA
      – PersonEntity:
          Name:
            NameFull: Confavreux C
      – PersonEntity:
          Name:
            NameFull: Galetta SL
      – PersonEntity:
          Name:
            NameFull: Rudick RA
      – PersonEntity:
          Name:
            NameFull: Lublin FD
      – PersonEntity:
          Name:
            NameFull: Weinstock-Guttman B
      – PersonEntity:
          Name:
            NameFull: Wynn DR
      – PersonEntity:
          Name:
            NameFull: Fisher E
      – PersonEntity:
          Name:
            NameFull: Papadopoulou A
      – PersonEntity:
          Name:
            NameFull: Lynn F
      – PersonEntity:
          Name:
            NameFull: Panzara MA
      – PersonEntity:
          Name:
            NameFull: Sandrock AW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 05
              Text: 2010 May 15
              Type: published
              Y: 2010
          Identifiers:
            – Type: issn-electronic
              Value: 1878-5883
          Numbering:
            – Type: volume
              Value: 292
            – Type: issue
              Value: 1-2
          Titles:
            – TitleFull: Journal of the neurological sciences
              Type: main
ResultId 1